Mark A. Goldsmith, See Remarks at Revolution Medicines, Inc. (RVMD), sold 71,600 shares at $98.17 ($7.2M) on 2026-03-02, disclosed to the SEC on 2026-03-03.
Seasonal sale ($7.2M) by See Remarks — this insider has traded RVMD in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.17 | 700 | $69K | 0.9% |
| 2 | $98.17 | 700 | $69K | 0.9% |
| 3 | $98.29 | 100 | $10K | 0.1% |
| 4 | $98.31 | 100 | $10K | 0.1% |
| 5 | $99.76 | 3,500 | $349K | 4.8% |
| 6 | $99.76 | 3,500 |
| $349K |
| 4.8% |
| 7 | $100.12 | 400 | $40K | 0.6% |
| 8 | $100.12 | 400 | $40K | 0.6% |
| 9 | $100.19 | 600 | $60K | 0.8% |
| 10 | $100.19 | 600 | $60K | 0.8% |
| 11 | $100.73 | 3,620 | $365K | 5.0% |
| 12 | $100.73 | 3,620 | $365K | 5.0% |
| 13 | $101.47 | 1,700 | $172K | 2.4% |
| 14 | $101.47 | 1,700 | $173K | 2.4% |
| 15 | $101.60 | 21,329 | $2.2M | 29.9% |
| 16 | $101.60 | 21,329 | $2.2M | 29.9% |
| 17 | $101.63 | 2,100 | $213K | 2.9% |
| 18 | $101.63 | 2,100 | $213K | 2.9% |
| 19 | $102.00 | 800 | $82K | 1.1% |
| 20 | $102.00 | 800 | $82K | 1.1% |
| 21 | $102.08 | 200 | $20K | 0.3% |
| 22 | $102.20 | 851 | $87K | 1.2% |
| 23 | $102.20 | 851 | $87K | 1.2% |
| Total | $101.24 avg | 71,600 | $7.2M | 100% |
| Filing → |
| RVMD | SELL | 2026-06-18 | $1.6M | — | Filing → |
| RVMD | SELL | 2026-04-17 | $18.0M | — | Filing → |
| RVMD | SELL | 2026-03-19 | $2.6M | — | Filing → |